Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)
Get Alerts AMGN Hot Sheet
Price: $284.32 -0.69%
Rating Summary:
20 Buy, 13 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
20 Buy, 13 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Analysts at Jefferies commented on short interest in the biotech space. The firm noted that as of as of December 27, 2011, weighted average short interest levels increased +0.5% for large-cap biotech stocks, fell 0.7% for mid-caps, remained relatively flat for smid-caps, and decreased -0.2% for small-cap and micro-caps.
In the large-cap biotech space, the ratio for Amgen (Nasdaq: AMGN) increased 1.9%. The increase in AMGN skewed the overall ratio. The remaining 4 large caps showed slight decreases in the ratio.
In mid-cap, United Therapeutics Corporation (NASDAQ: UTHR) and Onyx Pharmaceuticals (Nasdaq: ONXX) had the most significant decreases at t -3.5% and -1.2%, respectively. Regeneron Pharmaceuticals (Nasdaq: REGN) and Cubist Pharmaceuticals (Nasdaq: CBST) had the biggest increases at +0.3% and +0.1%, respectively.
In smid-caps, the most significant decreases in the ratio include NPS Pharmaceuticals (Nasdaq: NSPS) and Acorda Therapeutics (Nasdaq: ACOR) at -1.7% and -1.3, respectively. The most notable increases were in Dendreon (Nasdaq: DNDN) and Spectrum Pharmaceuticals (Nasdaq: SPPI) I at +2.0% and +1.6%, respectively.
In Small-caps, the most significant decreases in the ratio include Enzon Pharmaceuticals (Nasdaq: ENZN) and AMAG Pharmaceuticals (Nasdaq: AMAG) at -1.5% and -1.2%, respectively. The most notable increases were in Oncothyreon (Nasdaq: ONTY) and Synageva BioPharma (Nasdaq: GEVA) at +2.5% and +1.3%, respectively.
In Micro Caps, companies with the most significant decreases in the ratio include Metabolix (Nasdaq: MBLX) and GTx, Inc. (Nasdaq: GTXI) at -2.4% and -0.7%, respectively. y. Companies with notable increases in the ratio include Affymax (Nasdaq: AFFY) and Targacept (Nasdaq: TRGT) at +2.3% and +0.9%, respectively.
In the large-cap biotech space, the ratio for Amgen (Nasdaq: AMGN) increased 1.9%. The increase in AMGN skewed the overall ratio. The remaining 4 large caps showed slight decreases in the ratio.
In mid-cap, United Therapeutics Corporation (NASDAQ: UTHR) and Onyx Pharmaceuticals (Nasdaq: ONXX) had the most significant decreases at t -3.5% and -1.2%, respectively. Regeneron Pharmaceuticals (Nasdaq: REGN) and Cubist Pharmaceuticals (Nasdaq: CBST) had the biggest increases at +0.3% and +0.1%, respectively.
In smid-caps, the most significant decreases in the ratio include NPS Pharmaceuticals (Nasdaq: NSPS) and Acorda Therapeutics (Nasdaq: ACOR) at -1.7% and -1.3, respectively. The most notable increases were in Dendreon (Nasdaq: DNDN) and Spectrum Pharmaceuticals (Nasdaq: SPPI) I at +2.0% and +1.6%, respectively.
In Small-caps, the most significant decreases in the ratio include Enzon Pharmaceuticals (Nasdaq: ENZN) and AMAG Pharmaceuticals (Nasdaq: AMAG) at -1.5% and -1.2%, respectively. The most notable increases were in Oncothyreon (Nasdaq: ONTY) and Synageva BioPharma (Nasdaq: GEVA) at +2.5% and +1.3%, respectively.
In Micro Caps, companies with the most significant decreases in the ratio include Metabolix (Nasdaq: MBLX) and GTx, Inc. (Nasdaq: GTXI) at -2.4% and -0.7%, respectively. y. Companies with notable increases in the ratio include Affymax (Nasdaq: AFFY) and Targacept (Nasdaq: TRGT) at +2.3% and +0.9%, respectively.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Hennes & Mauritz AB (HMB:SS) (HNNMY) PT Raised to SEK190 at RBC Capital, 'showing some promising signs '
- Moderna (MRNA) PT Raised to $125 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!